Critical Path Institute

Be part of the global conversation shaping the future of drug development. The Critical Path Institute’s Global Impact Conference 2026 brings together regulators, industry leaders, scientists, clinicians, those with lived experience, and advocates for three days of high-impact dialogue and collaboration, all focused on accelerating better treatments for patients worldwide.

This is more than a conference — it’s a working forum where ideas turn into action. Join us as we redefine the evidence-generation enterprise for drug development in the 21st century. Through dynamic plenaries and interactive sessions, you’ll engage directly with leaders across the ecosystem on the most pressing challenges and opportunities, including:
- Innovative approaches to patient identification, enrichment, and stratification
- Bridging the gap between drug development and clinical care
- Advancing truly patient-centric clinical trials
- Leveraging real-world data to generate decision-ready evidence
- Integrating novel methodologies to support faster, more effective regulatory decisions

Each day is designed to move beyond discussion, culminating in clear priorities and actionable next steps that continue long after the meeting concludes.

If you are committed to advancing therapies and improving outcomes for patients, CGIC 2026 is where you need to be. Don’t miss your opportunity to connect, collaborate, and help shape what comes next.

Register now during early-bird pricing: https://f.mtr.cool/ypojgnbsop

At Critical Path Institute, collaboration, innovation, and sustainability aren't conference themes, they're how we work every day.

Through global public-private partnerships, we bring together industry, regulators, academia, and patient communities to accelerate the development of safe and effective therapies. From advancing regulatory science and data standards to developing tools that improve clinical trial design and decision-making, C-Path's work reflects the same principles driving dialogue at DIA 2026 collaboration that leads to real impact for patients.

Looking forward to engaging with partners at and continuing to move drug development forward, together. Don't miss the opportunity to connect with us at our posters and featured session:
1. Tuesday, June 16 | 111AB | 4:15 PM ET | SESSION "Operationalizing Large Language Models in Drug Development"
2. Wednesday, June 17 | 11:30 AM | POSTER "Glutamate Dehydrogenase (GLDH) as a Safety Biomarker: Applying a Regulatory Science Framework for Drug Development Tools"
3. Wednesday, June 17 | 11:30 AM | POSTER "Privacy-Preserving Federated Analysis Enables International Rare Disease Evidence Generation"

Dive into the world of solutions for Drug Development with C-Path's YouTube channel! Subscribe now for access to on-demand content including meetings, webinars, interviews, and more. Stay informed, stay inspired!

SUBSCRIBE to C-Path's YouTube Channel Now ►► https://f.mtr.cool/ptayoevfof